Evidence map›Paper›PMID 42649962›Full record

ArticleCancers2026

Microvessel Density as an Adjunctive Immunohistochemical Parameter in the Differential Diagnosis of Parathyroid Carcinoma and Adenoma-An Immunohistochemical Study.

Zorka Inić, Katarina Taušanović, Marko Buta, Zoran Kozomara, Ognjen Živković, Nikola Jeftić, Stefan Gačić, Dobrica Stević, Anđela Milićević, Milan Žegarac

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zorka InićClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0002-3159-891X
Katarina TaušanovićFaculty of Medicine, University of Belgrade, Dr Subotića 8, 11000 Belgrade, Serbia.
Marko ButaClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0001-8062-1250
Zoran KozomaraClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0003-2977-4037
Ognjen ŽivkovićDepartment of Pathology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0009-0008-1891-1677
Nikola JeftićClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0002-5768-6256
Stefan GačićClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
Dobrica StevićClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0001-9686-7044
Anđela MilićevićDepartment of Pathology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0009-0008-5392-5062
Milan ŽegaracClinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.ORCID 0000-0002-3917-541X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiogenesisbiomarkersendocrine tumorsimmunohistochemistrymicrovessel densityparathyroid adenomaparathyroid carcinomaprimary hyperparathyroidism

Identifiers

PMID42649962
PMCPMC13510844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.